Alternative NSAIDs to Celecoxib

Primary Alternative Strategy

The American Gastroenterological Association recommends using a non-selective NSAID (naproxen, diclofenac, or ibuprofen) combined with a proton pump inhibitor for gastroprotection, which provides equivalent gastrointestinal safety to celecoxib alone while being more cost-effective 1, 2
Diclofenac plus omeprazole showed comparable ulcer bleeding recurrence rates (6.4% or 12.8 per 100 patient-years) to celecoxib alone (4.9% or 9.8 per 100 patient-years) in high-risk patients with recent ulcer bleeding 2, 3
Proton pump inhibitors reduce bleeding ulcer risk by 75-85% in high-risk NSAID users 4, 5

Naproxen requires PPI co-therapy for gastroprotection in most patients, according to the American College of Gastroenterology 1
Diclofenac demonstrated equivalent safety to celecoxib when combined with PPI, as recommended by the American Gastroenterological Association 1, 2
Ibuprofen is comparable to other non-selective NSAIDs in efficacy, according to the European Society for Clinical Gastroenterology 2, 3

For low-risk patients, any non-selective NSAID is appropriate, with PPI co-therapy being uncertain or optional, as suggested by the American College of Gastroenterology 4
For high-risk patients, NSAID + PPI is appropriate, and COX-2 inhibitor + PPI is also appropriate but more expensive, according to the American Gastroenterological Association 4

All NSAIDs carry cardiovascular risk, including myocardial infarction, stroke, and hypertension, as warned by the American Heart Association 1, 5, 6
Mean blood pressure increases approximately 5 mm Hg with NSAID use, and monitoring blood pressure regularly is recommended by the American College of Cardiology 5
All NSAIDs can cause volume-dependent renal failure, interstitial nephritis, and nephrotic syndrome, and assessing renal function periodically is recommended by the National Kidney Foundation 5